Request for Nominations of Candidates To Serve on the Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/ATSDR), Centers for Disease Control and Prevention, Department of Health and Human Services (HHS), 39879-39880 [2011-16988]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 130 / Thursday, July 7, 2011 / Notices
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2011–16991 Filed 7–6–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Clinical Laboratory Improvement
Advisory Committee (CLIAC)
sroberts on DSK5SPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Times and Dates: 8:30 a.m.–5 p.m., August
31, 2011.
8:30 a.m.–12 p.m., September 1, 2011.
Place: CDC, 1600 Clifton Road, NE., Tom
Harkin Global Communications Center,
Building 19, Room 232, Auditorium B,
Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 100 people.
Purpose: This Committee is charged with
providing scientific and technical advice and
guidance to the Secretary of Health and
Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the
need for, and the nature of, revisions to the
standards under which clinical laboratories
are regulated; the impact on medical and
laboratory practice of proposed revisions to
the standards; and the modification of the
standards to accommodate technological
advances.
Matters to be Discussed: The agenda will
include agency updates from the CDC, the
Centers for Medicare & Medicaid Services
(CMS), and the Food and Drug
Administration (FDA); presentations and
discussions on the laboratory’s role in the
development and use of electronic health
records, electronic laboratory reporting for
notifiable diseases, and meaningful use; and
presentations and discussion on current
practices in gynecologic cytology testing.
Agenda items are subject to change as
priorities dictate.
Online Registration Required: In order to
expedite the security clearance process at the
CDC Roybal Campus located on Clifton Road,
all CLIAC attendees are required to register
for the meeting online at least 14 days in
advance at https://www.cdc.gov/cliac/
default.aspx by clicking the ‘‘Register for a
Meeting’’ link and completing all forms
according to the instructions given. Please
complete all the required fields before
submitting your registration and submit no
later than August 16, 2011.
Providing Oral or Written Comments: It is
the policy of CLIAC to accept written public
comments and provide a brief period for oral
public comments whenever possible. Oral
Comments: In general, each individual or
VerDate Mar<15>2010
16:26 Jul 06, 2011
Jkt 223001
group requesting to make an oral
presentation will be limited to a total time of
five minutes (unless otherwise indicated).
Speakers must also submit their comments in
writing for inclusion in the meeting’s
Summary Report. To assure adequate time is
scheduled for public comments, individuals
or groups planning to make an oral
presentation should, when possible, notify
the contact person below at least one week
prior to the meeting date. Written Comments:
For individuals or groups unable to attend
the meeting, CLIAC accepts written
comments until the date of the meeting
(unless otherwise stated); however, it is
requested that comments be submitted at
least one week prior to the meeting date so
that the comments may be made available to
the Committee for their consideration and
public distribution. Written comments, one
hard copy with original signature, should be
provided to the contact person below.
Written comments will be included in the
meeting’s Summary Report.
Contact Person for Additional Information:
Nancy Anderson, Chief, Laboratory Practice
Standards Branch, Division of Laboratory
Science and Standards, Laboratory Science,
Policy and Practice Program Office
(LSPPPO), Office of Surveillance,
Epidemiology and Laboratory Services, CDC,
1600 Clifton Road, NE., Mailstop F–11,
Atlanta, Georgia 30333; telephone (404) 498–
2741; fax (404) 498–2219; or via e-mail at
Nancy.Anderson@cdc.hhs.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
the Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: June 30, 2011.
Elizabeth Millington,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2011–17009 Filed 7–6–11; 8:45 am]
39879
Control and Prevention (CDC)
announces the aforementioned meeting:
Times and Dates: 8 a.m.–7 p.m., July 22,
2011 (Closed).
Place: Corporate Square, Building 8,
Atlanta, Georgia 30333.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘HIV Prevention Projects for
Young Men of Color Who Have Sex with Men
and Young Transgender Persons of Color,
FOA PS11–1113.’’ This subsequent meeting
to the July 10–13, 2011 meeting published in
the Federal Register on February 22, 2011,
Volume 76, Number 35, Pages 9785–9786 has
been scheduled due to the high volume of
applications received and unanticipated
scheduling conflicts for a significant number
of the appointed reviewers.
Contact Person for More Information:
Harriette Lynch, Public Health Analyst,
Extramural Programs, National Center for
HIV, Hepatitis and Sexually Transmitted
Diseases Prevention, CDC, 1600 Clifton Road,
NE., Mailstop E–60, Atlanta, Georgia 30333,
Telephone (404) 498–2726, E-mail
HLynch@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: June 30, 2011.
Elizabeth Millington,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2011–17008 Filed 7–6–11; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Human Immunodeficiency
Virus (HIV) Prevention Projects for
Young Men of Color Who Have Sex with
Men and Young Transgender Persons of
Color, Funding Opportunity
Announcement (FOA) PS11–1113,
initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)
Request for Nominations of
Candidates To Serve on the Board of
Scientific Counselors, National Center
for Environmental Health/Agency for
Toxic Substances and Disease
Registry (BSC, NCEH/ATSDR), Centers
for Disease Control and Prevention,
Department of Health and Human
Services (HHS)
The NCEH/ATSDR is soliciting
nominations for consideration of
membership on the BSC. The BSC,
NCEH/ATSDR provides advice and
guidance to the Secretary, HHS; the
Director, CDC; and the Director, NCEH/
E:\FR\FM\07JYN1.SGM
07JYN1
sroberts on DSK5SPTVN1PROD with NOTICES
39880
Federal Register / Vol. 76, No. 130 / Thursday, July 7, 2011 / Notices
ATSDR, regarding program goals,
objectives, strategies, and priorities in
fulfillment of the agencies’ mission to
protect and promote people’s health.
The Board provides advice and
guidance to help NCEH/ATSDR work
more efficiently and effectively with its
various constituents and to fulfill its
mission in protecting America’s health.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the Board’s
objectives. Nominees will be selected
from experts having experience in
preventing human diseases and
disabilities caused by environmental
conditions. Experts in the disciplines of
toxicology, epidemiology,
environmental or occupational
medicine, behavioral science, risk
assessment, exposure assessment, and
experts in public health and other
related disciplines will be considered.
Balanced membership will depend
upon several factors, including: (1) The
committee’s mission; (2) the geographic,
ethnic, social, economic, or scientific
impact of the advisory committee’s
recommendations; (3) the types of
specific perspectives required, for
example, those of consumers, technical
experts, the public at-large, academia,
business, or other sectors; (4) the need
to obtain divergent points of view on the
issues before the advisory committee;
and (5) the relevance of State, local, or
tribal governments to the development
of the advisory committee’s
recommendations. Members may be
invited to serve up to four-year terms.
Nominees must be U.S. citizens.
The following information must be
submitted for each candidate: Name,
affiliation, address, telephone number,
and current curriculum vitae. E-mail
addresses are requested if available.
Nominations should be sent, in writing,
and postmarked by October 31, 2011 to:
Sandra Malcom, Committee
Management Specialist, NCEH/ATSDR,
CDC, 4770 Buford Highway (MS–F61),
Chamblee, Georgia 30341. (E-mail
address: sym6@CDC.GOV). Telephone
and facsimile submissions cannot be
accepted.
Candidates invited to serve will be
asked to submit the ‘‘Confidential
Financial Disclosure Form for Special
Government Employees Serving on
Federal Advisory Committees at the
Centers for Disease Control and
Prevention.’’ This form allows CDC to
determine whether there is a statutory
conflict between that person’s public
responsibilities as a Special Government
Employee and private interests and
activities, or the appearance of a lack of
impartiality, as defined by Federal
VerDate Mar<15>2010
16:26 Jul 06, 2011
Jkt 223001
regulation. The form may be viewed and
downloaded at https://www.usoge.gov/
forms/oge450_pdf/
oge450_accessible.pdf. This form
should not be submitted as part of a
nomination.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: June 30, 2011.
Elizabeth A. Millington,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2011–16988 Filed 7–6–11; 8:45 am]
BILLING CODE 4163–18–P
Administration for Children and
Families
Announcement of a Grant Award
Office of Community Services,
ACF, HHS.
ACTION: Announcement of the Award of
an Assets for Independence Grant to the
United Way of Abilene, Inc., Abilene,
TX.
AGENCY:
Statutory Authority: Authorized under the
Assets for Independence Act in Title IV of
the Community Opportunities,
Accountability, and Training and
Educational Services Human Services
Reauthorization Act of 1998, Public Law
105–285, as amended.
The Administration for
Children and Families (ACF), Office of
Community Services (OCS), Division of
Community Demonstration Programs
announces the award of an Assets for
Independence (AFI) demonstration
grant to the United Way of Abilene, Inc.
of Abilene, TX in the amount of
$61,149.
The purpose of this award is to enable
the United Way of Abilene, Inc. to
implement an Assets for Independence
(AFI) project helping program
participants save earned income in
special-purpose, matched savings
accounts called Individual Development
Accounts (IDAs). Every dollar in savings
deposited into an IDA by participants is
matched, from $1 to $8 combined
Federal and non-Federal funds,
promoting savings and enabling
participants to acquire a lasting
economic asset. AFI project families use
SUMMARY:
Fmt 4703
Sfmt 4703
James Gatz, Program Manager, Assets for
Independence, Office of Community
Services, Administration for Children
and Families, U.S. Department of Health
and Human Services, 901 D Street, SW.,
5th floor East, Washington, DC 20047.
Telephone: 202–401–5284; E-mail:
james.gatz@acf.hhs.gov.
Dated: June 23, 2011.
Lynda E. Perez,
Acting Director, Division of Community
Demonstration Programs, Office of
Community Services.
[FR Doc. 2011–16973 Filed 7–6–11; 8:45 am]
BILLING CODE 4184–26–P
CFDA Number: 93.602.
Frm 00070
The project period for this award
is November 1, 2010 through September
29, 2011.
DATES:
FOR FURTHER INFORMATION CONTACT:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
their IDA savings, including the
matching funds, to achieve any of three
objectives: acquiring a first home;
capitalizing a small business; or
enrolling in postsecondary education or
training.
Additionally, the United Way of
Abilene, Inc. provides basic financial
management training and supportive
services, such as financial education on
owning and managing a bank account;
credit counseling and repair; guidance
in accessing refundable tax credits,
including the Earned Income Tax Credit
and the Child Tax Credit; and
specialized training in owning
particular economic assets for the long
term.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–D–0226]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Draft Guidance for
Industry, Third Parties and Food and
Drug Administration Staff; Medical
Device ISO 13485:2003 Voluntary Audit
Report Submission Program
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995
(PRA).
SUMMARY:
E:\FR\FM\07JYN1.SGM
07JYN1
]]>Agencies
[Federal Register Volume 76, Number 130 (Thursday, July 7, 2011)]
[Notices]
[Pages 39879-39880]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-16988]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention (CDC)
Request for Nominations of Candidates To Serve on the Board of
Scientific Counselors, National Center for Environmental Health/Agency
for Toxic Substances and Disease Registry (BSC, NCEH/ATSDR), Centers
for Disease Control and Prevention, Department of Health and Human
Services (HHS)
The NCEH/ATSDR is soliciting nominations for consideration of
membership on the BSC. The BSC, NCEH/ATSDR provides advice and guidance
to the Secretary, HHS; the Director, CDC; and the Director, NCEH/
[[Page 39880]]
ATSDR, regarding program goals, objectives, strategies, and priorities
in fulfillment of the agencies' mission to protect and promote people's
health. The Board provides advice and guidance to help NCEH/ATSDR work
more efficiently and effectively with its various constituents and to
fulfill its mission in protecting America's health.
Nominations are being sought for individuals who have expertise and
qualifications necessary to contribute to the accomplishments of the
Board's objectives. Nominees will be selected from experts having
experience in preventing human diseases and disabilities caused by
environmental conditions. Experts in the disciplines of toxicology,
epidemiology, environmental or occupational medicine, behavioral
science, risk assessment, exposure assessment, and experts in public
health and other related disciplines will be considered. Balanced
membership will depend upon several factors, including: (1) The
committee's mission; (2) the geographic, ethnic, social, economic, or
scientific impact of the advisory committee's recommendations; (3) the
types of specific perspectives required, for example, those of
consumers, technical experts, the public at-large, academia, business,
or other sectors; (4) the need to obtain divergent points of view on
the issues before the advisory committee; and (5) the relevance of
State, local, or tribal governments to the development of the advisory
committee's recommendations. Members may be invited to serve up to
four-year terms. Nominees must be U.S. citizens.
The following information must be submitted for each candidate:
Name, affiliation, address, telephone number, and current curriculum
vitae. E-mail addresses are requested if available. Nominations should
be sent, in writing, and postmarked by October 31, 2011 to: Sandra
Malcom, Committee Management Specialist, NCEH/ATSDR, CDC, 4770 Buford
Highway (MS-F61), Chamblee, Georgia 30341. (E-mail address:
sym6@CDC.GOV). Telephone and facsimile submissions cannot be accepted.
Candidates invited to serve will be asked to submit the
``Confidential Financial Disclosure Form for Special Government
Employees Serving on Federal Advisory Committees at the Centers for
Disease Control and Prevention.'' This form allows CDC to determine
whether there is a statutory conflict between that person's public
responsibilities as a Special Government Employee and private interests
and activities, or the appearance of a lack of impartiality, as defined
by Federal regulation. The form may be viewed and downloaded at https://www.usoge.gov/forms/oge450_pdf/oge450_accessible.pdf. This form
should not be submitted as part of a nomination.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention, and the Agency
for Toxic Substances and Disease Registry.
Dated: June 30, 2011.
Elizabeth A. Millington,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2011-16988 Filed 7-6-11; 8:45 am]
BILLING CODE 4163-18-P
